Ticker Symbol | Entity Name | As Of Date | Company Name | Followers | Employees on Linkedin | Link | Industry | Date Added | Date Updated | Description | Website | Specialities | Logo | HQ.Street | HQ.City | HQ.State | HQ.Country | HQ.Postal | Headcount change in past 24 months | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
private:deliniabio | 10846555 | Nov 18th, 2019 12:00AM | Delinia | 164 | 0.00 | Open | Biotechnology | Nov 18th, 2019 04:07PM | Nov 18th, 2019 04:07PM | Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. | Open | Open | 953 Indiana Street | San Francisco | California (CA) | US | 94107 | Delinia | ||||
private:deliniabio | 10846555 | Nov 17th, 2019 12:00AM | Delinia | 164 | 0.00 | Open | Biotechnology | Nov 17th, 2019 04:33PM | Nov 17th, 2019 04:33PM | Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. | Open | Open | 953 Indiana Street | San Francisco | California (CA) | US | 94107 | Delinia | ||||
private:deliniabio | 10846555 | Nov 16th, 2019 12:00AM | Delinia | 164 | 0.00 | Open | Biotechnology | Nov 16th, 2019 04:27PM | Nov 16th, 2019 04:27PM | Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. | Open | Open | 953 Indiana Street | San Francisco | California (CA) | US | 94107 | Delinia | ||||
private:deliniabio | 10846555 | Nov 15th, 2019 12:00AM | Delinia | 164 | 0.00 | Open | Biotechnology | Nov 15th, 2019 01:05PM | Nov 15th, 2019 01:05PM | Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. | Open | Open | 953 Indiana Street | San Francisco | California (CA) | US | 94107 | Delinia | ||||
private:deliniabio | 10846555 | Nov 13th, 2019 12:00AM | Delinia | 164 | 0.00 | Open | Biotechnology | Nov 13th, 2019 01:29PM | Nov 13th, 2019 01:29PM | Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. | Open | Open | 953 Indiana Street | San Francisco | California (CA) | US | 94107 | Delinia | ||||
private:deliniabio | 10846555 | Nov 12th, 2019 12:00AM | Delinia | 164 | 0.00 | Open | Biotechnology | Nov 12th, 2019 03:10PM | Nov 12th, 2019 03:10PM | Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. | Open | Open | 953 Indiana Street | San Francisco | California (CA) | US | 94107 | Delinia | ||||
private:deliniabio | 10846555 | Nov 11th, 2019 12:00AM | Delinia | 164 | 0.00 | Open | Biotechnology | Nov 11th, 2019 03:08PM | Nov 11th, 2019 03:08PM | Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. | Open | Open | 953 Indiana Street | San Francisco | California (CA) | US | 94107 | Delinia | ||||
private:deliniabio | 10846555 | Nov 10th, 2019 12:00AM | Delinia | 164 | 0.00 | Open | Biotechnology | Nov 10th, 2019 06:15PM | Nov 10th, 2019 06:15PM | Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. | Open | Open | 953 Indiana Street | San Francisco | California (CA) | US | 94107 | Delinia | ||||
private:deliniabio | 10846555 | Nov 9th, 2019 12:00AM | Delinia | 164 | 0.00 | Open | Biotechnology | Nov 9th, 2019 05:42PM | Nov 9th, 2019 05:42PM | Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. | Open | Open | 953 Indiana Street | San Francisco | California (CA) | US | 94107 | Delinia | ||||
private:deliniabio | 10846555 | Nov 8th, 2019 12:00AM | Delinia | 164 | 0.00 | Open | Biotechnology | Nov 8th, 2019 02:53PM | Nov 8th, 2019 02:53PM | Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. | Open | Open | 953 Indiana Street | San Francisco | California (CA) | US | 94107 | Delinia |